US Patent Issued to THE PROVOST, FELLOWS, SCHOLARS AND OTHER MEMBERS OF BOARD OF TRINITY COLLEGE DUBLIN, UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN on Feb. 10 for "Method of predicting risk of recurrence of cancer" (Irish Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,961, issued on Feb. 10, was assigned to THE PROVOST, FELLOWS, SCHOLARS AND OTHER MEMBERS OF BOARD OF TRINITY COLLEGE DUBLIN (Dublin) and UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN (Dublin).

"Method of predicting risk of recurrence of cancer" was invented by Adrian Bracken (Dublin), Fiona Lanigan (Dublin) and William Gallagher (Dublin).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for predicting risk of recurrence of cancer in an individual with cancer, the method comprising a step of assaying a cancer sample from the individual for positive expression of at least two genes or proteins encoded by those genes selected f...